The secondary peptide metabolites produced by the Trichoderma asperellum strain F-1087 were isolated, and their properties were studied. It has been shown these metabolites at concentrations of 0.08 and 0.02 mg/mL inhibit the human prostate cancer cell line by 97 and 34%, respectively.
